Development and Biophysical Characterization of a Humanized FSH-Blocking Monoclonal Antibody Therapeutic Formulated at an Ultra-High Concentration
S. Rojekar, A. R. Pallapati, J. Gimenez-Roig, F. Korkmaz, F. Sultana, D. Sant, C. M. Haeck, A. Macdonald, S.-M. Kim, C. J. Rosen, O. Barak, M. Meseck, J. Caminis, D. Lizneva, T. Yuen, M. Zaidi
This paper develops a stable, high-concentration formulation of a humanized FSH-blocking antibody and validates its physicochemical and thermal stability.
bioRxiv · May 11, 2023Bioengineering